| TTM
|
12/31/2025
|
12/31/2024
|
|
|---|---|---|---|
| Total Revenue
|
6,127 | 3,449 | 0 |
| Selling, General and Administrative Expenses
|
-22,563 | -20,302 | -14,876 |
|
Research and Development Expenses
|
-89,866 | -71,512 | -43,357 |
|
Operating Income/Expenses
|
-112,429 | -91,814 | -58,233 |
|
Total Operating Profit/Loss
|
-106,302 | -88,365 | -58,233 |
| Total Net Finance Income/Expense
|
16,655 | 13,641 | 11,395 |
|
Other Income/Expense, Non-Operating
|
1,777 | 1,636 | 478 |
|
Non-Operating Income/Expenses, Total
|
18,432 | 15,277 | 11,873 |
|
Pretax Income
|
-87,870 | -73,088 | -46,360 |
|
Net Income from Continuing Operations
|
-87,870 | -73,088 | -46,360 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-87,870 | -73,088 | -46,360 |
|
Net Income after Non-Controlling/Minority Interests
|
-87,870 | -73,088 | -46,360 |
|
Net Income Available to Common Stockholders
|
-87,870 | -73,088 | -46,360 |
|
Diluted Net Income Available to Common Stockholders
|
-87,870 | -73,088 | -46,360 |
| Basic EPS
|
-1.16 | -0.97 | -0.62 |
| Diluted EPS
|
-1.16 | -0.97 | -0.62 |
|
Basic Weighted Average Shares Outstanding
|
75,346.35 | 75,346.35 | 75,310.30 |
|
Diluted Weighted Average Shares Outstanding
|
75,346.35 | 75,346.35 | 75,310.30 |
| Income Statement, Supplemental
|
|||
|
EBIT
|
-104,525 | -86,729 | -57,755 |
|
EBITDA
|
-101,883 | -84,402 | -56,253 |
|
Normalized EBITDA
|
-96,289 | -78,275 | -52,305 |
|
Normalized Income
|
-82,276 | -66,961 | -42,412 |
|
Total Unusual Items
|
5,594 | 6,127 | 3,948 |
|
Total Unusual Items Excluding Goodwill
|
5,594 | 6,127 | 3,948 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 |
12/31/2024 - 9/25/2026
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade